These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
204 related items for PubMed ID: 32332068
1. Lactobacillus salivarius AP-32 and Lactobacillus reuteri GL-104 decrease glycemic levels and attenuate diabetes-mediated liver and kidney injury in db/db mice. Hsieh PS, Ho HH, Hsieh SH, Kuo YW, Tseng HY, Kao HF, Wang JY. BMJ Open Diabetes Res Care; 2020 Apr; 8(1):. PubMed ID: 32332068 [Abstract] [Full Text] [Related]
2. Adjuvant Probiotics of Lactobacillus salivarius subsp. salicinius AP-32, L. johnsonii MH-68, and Bifidobacterium animalis subsp. lactis CP-9 Attenuate Glycemic Levels and Inflammatory Cytokines in Patients With Type 1 Diabetes Mellitus. Wang CH, Yen HR, Lu WL, Ho HH, Lin WY, Kuo YW, Huang YY, Tsai SY, Lin HC. Front Endocrinol (Lausanne); 2022 Apr; 13():754401. PubMed ID: 35299968 [Abstract] [Full Text] [Related]
3. The beneficial effects of Lactobacillus reuteri ADR-1 or ADR-3 consumption on type 2 diabetes mellitus: a randomized, double-blinded, placebo-controlled trial. Hsieh MC, Tsai WH, Jheng YP, Su SL, Wang SY, Lin CC, Chen YH, Chang WW. Sci Rep; 2018 Nov 14; 8(1):16791. PubMed ID: 30429496 [Abstract] [Full Text] [Related]
4. Multi-strain probiotic supplement attenuates streptozotocin-induced type-2 diabetes by reducing inflammation and β-cell death in rats. Hsieh PS, Ho HH, Tsao SP, Hsieh SH, Lin WY, Chen JF, Kuo YW, Tsai SY, Huang HY. PLoS One; 2021 Nov 14; 16(6):e0251646. PubMed ID: 34166387 [Abstract] [Full Text] [Related]
5. Selection of Fermentation Supernatant from Probiotic Strains Exhibiting Intestinal Epithelial Barrier Protective Ability and Evaluation of Their Effects on Colitis Mouse and Weaned Piglet Models. Abrehame S, Hung MY, Chen YY, Liu YT, Chen YT, Liu FC, Lin YC, Chen YP. Nutrients; 2024 Apr 12; 16(8):. PubMed ID: 38674829 [Abstract] [Full Text] [Related]
6. Improvement in glucose tolerance and insulin sensitivity by probiotic strains of Indian gut origin in high-fat diet-fed C57BL/6J mice. Balakumar M, Prabhu D, Sathishkumar C, Prabu P, Rokana N, Kumar R, Raghavan S, Soundarajan A, Grover S, Batish VK, Mohan V, Balasubramanyam M. Eur J Nutr; 2018 Feb 12; 57(1):279-295. PubMed ID: 27757592 [Abstract] [Full Text] [Related]
7. Elucidating the Mechanisms of Cell-to-Cell Crosstalk in Probiotics Co-culture: A Proteomics Study of Limosilactobacillus reuteri ZJ625 and Ligilactobacillus salivarius ZJ614. Kwoji ID, Aiyegoro OA, Okpeku M, Adeleke MA. Probiotics Antimicrob Proteins; 2024 Oct 12; 16(5):1817-1835. PubMed ID: 37581751 [Abstract] [Full Text] [Related]
8. Histamine H2 Receptor-Mediated Suppression of Intestinal Inflammation by Probiotic Lactobacillus reuteri. Gao C, Major A, Rendon D, Lugo M, Jackson V, Shi Z, Mori-Akiyama Y, Versalovic J. mBio; 2015 Dec 15; 6(6):e01358-15. PubMed ID: 26670383 [Abstract] [Full Text] [Related]
9. In vitro evaluation of anticancer effects of different probiotic strains on HCT-116 cell line. Yenuganti VR, Yadala R, Azad R, Singh S, Chiluka V, Ahire J, Reddanna P. J Appl Microbiol; 2021 Oct 15; 131(4):1958-1969. PubMed ID: 33694215 [Abstract] [Full Text] [Related]
10. Lactobacillus salivarius LI01 encapsulated in alginate-pectin microgels ameliorates D-galactosamine-induced acute liver injury in rats. Zhuge A, Li B, Yuan Y, Lv L, Li Y, Wu J, Yang L, Bian X, Wang K, Wang Q, Yan R, Zhu X, Li L. Appl Microbiol Biotechnol; 2020 Sep 15; 104(17):7437-7455. PubMed ID: 32666187 [Abstract] [Full Text] [Related]
11. Lactobacillus gasseri CKCC1913 mediated modulation of the gut-liver axis alleviated insulin resistance and liver damage induced by type 2 diabetes. Jiang S, Liu A, Ma W, Liu X, Luo P, Zhan M, Zhou X, Chen L, Zhang J. Food Funct; 2023 Sep 19; 14(18):8504-8520. PubMed ID: 37655696 [Abstract] [Full Text] [Related]
12. Metabolic effects of Lactobacillus reuteri DSM 17938 in people with type 2 diabetes: A randomized controlled trial. Mobini R, Tremaroli V, Ståhlman M, Karlsson F, Levin M, Ljungberg M, Sohlin M, Bertéus Forslund H, Perkins R, Bäckhed F, Jansson PA. Diabetes Obes Metab; 2017 Apr 19; 19(4):579-589. PubMed ID: 28009106 [Abstract] [Full Text] [Related]
13. Oral treatment with live Lactobacillus reuteri inhibits the allergic airway response in mice. Forsythe P, Inman MD, Bienenstock J. Am J Respir Crit Care Med; 2007 Mar 15; 175(6):561-9. PubMed ID: 17204726 [Abstract] [Full Text] [Related]
14. Limosilactobacillus reuteri BIO7251 administration improves metabolic phenotype in obese mice fed a high fat diet: an inter-organ crosstalk between gut, adipose tissue and nervous system. Abot A, Pomié N, Astre G, Jaomanjaka F, Marchand P, Cani PD, Roudier N, Knauf C. Int J Food Sci Nutr; 2024 Feb 15; 75(1):58-69. PubMed ID: 37921224 [Abstract] [Full Text] [Related]
15. Antibacterial activity of viable and heat-killed probiotic strains against oral pathogens. Chen YT, Hsieh PS, Ho HH, Hsieh SH, Kuo YW, Yang SF, Lin CW. Lett Appl Microbiol; 2020 Apr 15; 70(4):310-317. PubMed ID: 31955445 [Abstract] [Full Text] [Related]
16. Lactobacillus reuteri attenuated allergic inflammation induced by HDM in the mouse and modulated gut microbes. Li L, Fang Z, Liu X, Hu W, Lu W, Lee YK, Zhao J, Zhang H, Chen W. PLoS One; 2020 Apr 15; 15(4):e0231865. PubMed ID: 32315360 [Abstract] [Full Text] [Related]
17. Effect of addition of a probiotic micro-organism to broiler diet on intestinal mucosal architecture and electrophysiological parameters. Awad WA, Ghareeb K, Böhm J. J Anim Physiol Anim Nutr (Berl); 2010 Aug 01; 94(4):486-94. PubMed ID: 19906141 [Abstract] [Full Text] [Related]
18. The beneficial effects of the composite probiotics from camel milk on glucose and lipid metabolism, liver and renal function and gut microbiota in db/db mice. Manaer T, Yu L, Nabi XH, Dilidaxi D, Liu L, Sailike J. BMC Complement Med Ther; 2021 Apr 22; 21(1):127. PubMed ID: 33888105 [Abstract] [Full Text] [Related]
19. Conjugal transfer of erm(B) and multiple tet genes from Lactobacillus spp. to bacterial pathogens in animal gut, in vitro and during food fermentation. Thumu SCR, Halami PM. Food Res Int; 2019 Feb 22; 116():1066-1075. PubMed ID: 30716890 [Abstract] [Full Text] [Related]
20. In vitro inhibitory effect of two commercial probiotics on chromogenic actinomycetes. Gobbi E, De Francesco MA, Piccinelli G, Caruso A, Bardellini E, Majorana A. Eur Arch Paediatr Dent; 2020 Dec 22; 21(6):673-677. PubMed ID: 32034698 [Abstract] [Full Text] [Related] Page: [Next] [New Search]